Accordingly, inhibiting the activity of ERK, P38, c-Myc, or the glycolytic enzyme PFKFB3 in functional Breg cells from patients with SLE effectively impairs the polarization of pathogenic inflammatory TH cell subsets. This evidence concerns the gene MYC and systemic lupus erythematosus.